Results 1 -
3 of
3
SYSTOLIC ARITHMETIC ARCHITECTURES
"... Abstract:- In this paper parallel-ism on che algorithmic, architec-tural, and arithmetic levels is exploited in the design of a Residue Number System (RNS) based archite:;ture. The architecture is basecl on modulo processors. Each modulo processor is imple-mented 1:)y two dimensional systol-ic arr,: ..."
Abstract
- Add to MetaCart
,:iy composed of very simple cells. 'rhe decoding stage is im-plementled using a 2-D array, too. The dec:ading bottleneck is elim-inated. The whole architecture is pipelincd which lead to high throughput rate.- 1. Introduction: In
Overcoming Performance Bottlenecks in Using OpenMP on SMP Clusters Woo-Chul Jeun a Yang-Suk Kee b, ∗ Soonhoi Ha a
"... This paper presents a new parallel programming environment called ParADE to enable easy, portable, and high-performance computing for SMP clusters. Different from the prior studies, ParADE separates the programming model from the exe-cution model: it enables shared-address-space programming while it ..."
Abstract
- Add to MetaCart
This paper presents a new parallel programming environment called ParADE to enable easy, portable, and high-performance computing for SMP clusters. Different from the prior studies, ParADE separates the programming model from the exe-cution model: it enables shared-address-space programming while
Integration of the Hybrid Adenoretroviral Vector AdLTR-luc Involves Both MoMLV Elements Flanking the
"... licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. Received: 2014.03.11; Accepted: 2014.05.26; Published: 2014.06.01 Vector delivery is still a bottleneck for gene therapy. To overcome some disadv ..."
Abstract
- Add to MetaCart
licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. Received: 2014.03.11; Accepted: 2014.05.26; Published: 2014.06.01 Vector delivery is still a bottleneck for gene therapy. To overcome some